Further studies are needed to explore the precise molecular mechanisms by which NF-κB influences cardiac aging and to determine whether modulating this pathway can effectively prevent or delay age-associated cardiovascular diseases. This evidence concerns the gene NFKB1 and cardiovascular disorder.